Immunology of bipolar disorder;Imunologia do transtorno bipolar

Jornal Brasileiro de Psiquiatria

Volumn 58, Issue 1, 2009, Pages 52-59

  Barbosa, Izabela Guimarães ^a   Huguet, Rodrigo Barreto ^b   Neves, Fernando Silva ^a   Bauer, Moisés Evandro ^c   Teixeira, Antônio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital Governador Israel Pinheiro   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bipolar disorder; Chemokines; Cytokines; Immunology; Interferon and tumor necrosis factor ; Interleukins

Indexed keywords

AUTOANTIBODY; CHEMOKINE; CYTOKINE; INTERFERON; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; BIPOLAR DISORDER; DATA BASE; DISEASE ASSOCIATION; HUMAN; IMMUNITY; MANIA; MEDLINE; REVIEW; SYSTEMATIC REVIEW;

EID: 67650165236     PISSN: 00472085     EISSN: 19820208     Source Type: Journal    
DOI: 10.1590/S0047-20852009000100009     Document Type: Review

References (51)

1. Belmaker RH. Bipolar disorder. N Engl J Med. 2004;351(5):476-486
2. Benazzi F. Bipolar II disorder: epidemiology, diagnosis and management. CNS Drugs. 2007;21(9):27-40. (Pubitemid 47294719)
3. Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D, et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol. 2003;6(2):127-137 (Pubitemid 36850965)
4. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67(1):1-8.
5. Beyer J, Kuchibhatla M, Gersing K, Krishnan KR. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology. 2005;30(2):401-404 (Pubitemid 40129491)
6. Merikangas K, Yu K. Genetic epidemiology of bipolar disorder. Clin Neurosci Res. 2002;2:127-141
7. Carter CJ. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochem Int. 2007;50(3):461-490 (Pubitemid 46186608)
8. Serretti A, Mandelli L. The genetics of bipolar disorder: genome 'hot regions', genes, new potential candidates and future directions. Mol Psychiatry. 2008;13(8):742-771
9. Simon NM, McNamarab K, Chowa CW, Maserb RS, Papakostas GI, Pollacka MH, et al. A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol. 2008;18:230-233
10. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, et al. Pro- and antiinflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol. 2007:763-796 (Pubitemid 351171870)
11. Teixeira AL, Bauer ME, Nicolato R, Reis HJ, Palotás A. Cytokines and the brain: beyond immune response. In: Fedorovich SV (ed.). Signal Transduction in Nervous Cells, India; 2008.
12. da Rocha FF, Correa H, Teixeira AL. Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1139-1146
13. Coelho FM, Reis HJ, Nicolato R, Romano-Silva MA, Teixeira MM, Bauer ME, Teixeira AL. Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation. 2008;15(2):140-144
14. Teixeira AL, Reis HJ, Nicolato R, Brito-Melo G, Correa H, Teixeira MM, et al. Increased serum levels of CCL11/eotaxin in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(3):710-714 (Pubitemid 351312370)
15. Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol. 2005;18(1):41-78. (Pubitemid 40586446)
16. Pae CU, Lee KU, Han H, Serretti A, Jun TY. Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population. Psychiatry Res. 2004;125(1):65-68 (Pubitemid 38210254)
17. Papiol S, Rosa A, Gutiérrez B, Martín B, Salgado P, Catalán R, et al. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet. 2004;41(3):219-223 (Pubitemid 38333802)
18. Kim SJ, Lee HJ, Koo HG, Kim JW, Song JY, Kim MK, et al. Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder. Psychiatr Genet. 2004;14(3):165-167 (Pubitemid 39281826)
19. Roh MS, Lee KY, Joo EJ, Lee N, Kim YS. No association of the MCP-1 promoter A-2518G polymorphism with bipolar disorder in the Korean population. Neurosci Lett. 2007;427(1):1-5. (Pubitemid 47599784)
20. Czerski PM, Rybakowski F, Kapelski P, Rybakowski JK, Dmitrzak-Weglarz M, Leszczyńska-Rodziewicz A. Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population. Neuropsychobiology. 2008;57(1-2):88-94. (Pubitemid 351859339)
21. Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 2008;65(4):395-407.
22. Rapaport MH. Immune parameters in euthymic bipolar patients and normal volunteers. J Affect Disord. 1994;32:149-156 (Pubitemid 24341678)
23. Hornig M, Amsterdam JD, Kamoun M, Goodman DB. Autoantibody disturbances in affective disorders: a function of age and gender? J Affect Disord. 1999;55(1):29-37.
24. Kupka RW, Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD, et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry. 2002;51(4):305-311 (Pubitemid 34214996)
25. Baethge C, Blumentritt H, Berghöfer A, Bschor T, Glenn T, Adli M, et al. Long-term lithium treatment and thyroid antibodies: a controlled study. J Psychiatry Neurosci. 2005;30(6):423-427 (Pubitemid 41812489)
26. Padmos RC, Bekris L, Knijff EM, Tiemeier H, Kupka RW, Cohen D, et al. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry. 2004;56(7):476-482 (Pubitemid 39278244)
27. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995;29(2):141-152
28. Rapaport MH, Guylai L, Whybrow P. Immune parameters in rapid cycling bipolar patients before and after lithium treatment. J Psychiatr Res. 1999;33(4):335-340 (Pubitemid 29267636)
29. Tsai SY, Yang YY, Kuo CJ, Chen CC, Leu SJ. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord. 2000;64(2-3):185-193
30. Kim YK, Suh IB, Kim H, Han CS, Lim CS, Choi SH, et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry. 2002;7(10):1107-1114 (Pubitemid 36044270)
31. Breunis MN, Kupka RW, Nolen WA, Suppes T, Denicoff KD, Leverich GS, et al. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biol Psychiatry. 2003;53(2):157-165 (Pubitemid 36126479)
32. Kim YK, Myint AM, Lee BH, Han CS, Lee SW, Leonard BE, et al. T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients. Psychiatry Res. 2004;129(3):267-272
33. O'Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord. 2006;90(2-3):263-267 (Pubitemid 43183536)
34. Ortiz-Domínguez A, Hernández ME, Berlanga C, Gutiérrez-Mora D, Moreno J, Heinze G, et al. Immune variations in bipolar disorder: phasic differences. Bipolar Disord. 2007;9(6):596-602. (Pubitemid 47365627)
35. Hung YJ, Hsieh CH, Chen YJ, Pei D, Kuo SW, Shen DC, et al. Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol (Oxf). 2007;67(5):784-789 (Pubitemid 47628469)
36. Kauer-Sant'anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Trevor Young L, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2008;4:1-12.
37. Sourlingas TG, Issidorides MR, Havaki S, Trikkas G, Sekeri-Pataryas KE. Peripheral blood lymphocytes of bipolar affective patients have a histone synthetic profile indicative of an active cell state. Prog Neuropsychopharmacol Biol Psychiatry. 1998;22(1):81-96. (Pubitemid 28096430)
38. Cassidy F, Wilson WH, Carroll BJ. Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation. Acta Psychiatr Scand. 2002;105(1):60-64 (Pubitemid 34158069)
39. Su KP, Leu SJ, Yang YY, Shen WW, Chou YM, Tsai SY. Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission. J Affect Disord. 2002;71(1-3):205-209 (Pubitemid 34886427)
40. Boufidou F, Nikolaou C, Alevizos B, Liappas IA, Christodoulou GN. Cytokine production in bipolar affective disorder patients under lithium treatment. J Affect Disord. 2004;82(2):309-313 (Pubitemid 39370835)
41. Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ. Immunologic variables in acute mania of bipolar disorder. J Neuroimmunol. 2004;150(1-2):116-122 (Pubitemid 38481654)
42. Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord. 2007;104(1-3):91-95 (Pubitemid 350064526)
43. Knijff EM, Breunis MN, Kupka RW, de Wit HJ, Ruwhof C, Akkerhuis GW, et al. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord. 2007;9(7):743-753 (Pubitemid 350042410)
44. Hillegers MH, Reichart CG, Wals M, Verhulst FC, Ormel J, Nolen WA, et al. Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents. Eur Neuropsychopharmacol. 2007;17(6-7):394-399 (Pubitemid 46497656)
45. O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol. 2008;252(1-2):91-110.
46. Kop WJ, Cohen N. Psychoneuroimmunological pathways involved in acute coronary syndromes. In: Ader R (ed.). Psychoneuroimmunology. New York: Elsevier Press; 2007. p. 921-944
47. Guest CB, Gao Y, O'Connor JC, Freund GG. Obesity and Immunity. In: Ader R (ed.). Psychoneuroimmunology. New York: Elsevier Press; 2007. p. 933-1012.
48. Schleifer SJ. Psychoneuroimmunologic aspects of alcohol and substance abuse. In: Ader R (ed.). Psychoneuroimmunology. New York: Elsevier Press; 2007. p. 549-562
49. Moreira MA, Souza AL, Lana-Peixoto MA, Teixeira MM, Teixeira AL. Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis. Braz J Med Biol Res. 2006;39(4):441-445
50. Rapaport MH, Manji HK. The effects of lithium on ex vivo cytokine production. Biol Psychiatry. 2001;50(3):217-224 (Pubitemid 32763100)
51. Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol. 2008;23(2):87-94. (Pubitemid 351359580)